Given the strong but complex role of the MHC in MS, inclusion of susceptibility variants from that region will further improve the prediction in European populations but may be less informative in diverse population given the rapid and copmplex evoluation of the MHC which harbors many population-specific effects. The gene discussed is HLA-C; the disease is myeloid sarcoma.